Healthcare Sector Actividad de insiders

Sigue las compras y ventas de insiders en acciones de Healthcare. Descubre qué ejecutivos compran, la actividad neta de insiders y el % del capital flotante negociado en 3,224 empresas.
La información que se muestra en esta pantalla tiene fines meramente informativos y no constituye asesoramiento financiero. No recomendamos ninguna inversión específica basándonos en estos criterios.
Empresas
Datos
Suscríbase para acceder a todos los datos.
Compañía Sector empresarial Capitalización de mercado ($) # Compras netas de insiders Valor neto de la compra ($) % de flotación comprada % de acciones en manos de insiders
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No hay actividad — 15–50%
Healthcare Services Mid (2.2bn) 0 No hay actividad — 15–50%
US 89Bio Inc (ETNB)
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No hay actividad — 0–15%
IN Natco Pharma Ltd (NATCOPHARM)
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No hay actividad — 50%+
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No hay actividad — 0–15%
US Kardigan Inc (KARD)
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No hay actividad — 15–50%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) -1–5 -$100K–$1M -0–15% 0–15%
FR Orpea SA (ORP)
Healthcare Services Mid (2.1bn) 0 No hay actividad — 0–15%
Healthcare Services Mid (2.1bn) 0 No hay actividad — 0–15%
BE Fagron NV (FAGR)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No hay actividad — 0–15%
AU Ansell Ltd (ANN)
Healthcare Services Mid (2.1bn) 0 No hay actividad — 0–15%
CH Idorsia Ltd (IDIA)
Pharmaceuticals & Medical Research Mid (2.1bn) -1–5 -< $100K -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No hay actividad — 0–15%
SE AddLife AB (ALIF-B)
Pharmaceuticals & Medical Research Mid (2.1bn) 1–5 < $100K 0–15% 0–15%
US NuVasive Inc (NUVA)
Healthcare Services Mid (2.1bn) 0 No hay actividad — 0–15%
CH BB Biotech AG (BION)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No hay actividad — 15–50%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No hay actividad — 15–50%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No hay actividad — 15–50%
Pharmaceuticals & Medical Research Mid (2.1bn) -1–5 -$100K–$1M -0–15% 0–15%
US Xencor Inc (XNCR)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (2.0bn) 0 No hay actividad — 0–15%
Healthcare Services Mid (2.0bn) 0 No hay actividad — 15–50%
Pharmaceuticals & Medical Research Mid (2.0bn) 0 No hay actividad — 0–15%
Healthcare Services Mid (2.0bn) -1–5 $1M–$10M 0–15% 0–15%
IN Jubilant Pharmova Ltd (JUBLPHARMA)
Pharmaceuticals & Medical Research Mid (2.0bn) 0 No hay actividad — 50%+
Pharmaceuticals & Medical Research Small (2.0bn) 0 No hay actividad — 0–15%
SE Vimian Group AB (VIMIAN)
Healthcare Services Small (2.0bn) -1–5 $10M–$100M 50%+ 0–15%
US Quidel Corp (QDEL)
Healthcare Services Small (2.0bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 No hay actividad — 50%+
US Zymeworks Inc (ZYME)
Pharmaceuticals & Medical Research Small (1.9bn) 0 No hay actividad — 0–15%
GB Genus PLC (GNS)
Pharmaceuticals & Medical Research Small (1.9bn) 1–5 < $100K 0–15% 0–15%
SE Elekta AB (publ) (EKTA-B)
Healthcare Services Small (1.9bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) 0 No hay actividad — 15–50%
Pharmaceuticals & Medical Research Small (1.9bn) 0 No hay actividad — 0–15%
Healthcare Services Small (1.9bn) 0 No hay actividad — 0–15%
Healthcare Services Small (1.9bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Small (1.9bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No hay actividad — 0–15%
BE Galapagos NV (GLPG)
Pharmaceuticals & Medical Research Small (1.8bn) 0 No hay actividad — 15–50%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No hay actividad — 0–15%
US Novocure Ltd (NVCR)
Healthcare Services Small (1.8bn) -6–10 -$1M–$10M -0–15% 0–15%
Healthcare Services Small (1.8bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No hay actividad — 15–50%
Healthcare Services Small (1.8bn) 0 No hay actividad — 0–15%
Healthcare Services Small (1.8bn) 0 No hay actividad — 0–15%
Healthcare Services Small (1.8bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No hay actividad — 0–15%
Healthcare Services Small (1.8bn) 0 No hay actividad — 0–15%
US Septerna Inc (SEPN)
Pharmaceuticals & Medical Research Small (1.8bn) 0 No hay actividad — 0–15%
US Luminex Corp (LMNX)
Healthcare Services Small (1.8bn) 0 No hay actividad — 0–15%
US Galecto Inc (GLTO)
Pharmaceuticals & Medical Research Small (1.7bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$100K–$1M -0–15% 0–15%
US Novavax Inc (NVAX)
Pharmaceuticals & Medical Research Small (1.7bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No hay actividad — 0–15%
Healthcare Services Small (1.7bn) 1–5 < $100K 0–15% 15–50%
US Omnicell Inc (OMCL)
Healthcare Services Small (1.7bn) 0 No hay actividad — 0–15%
Healthcare Services Small (1.7bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No hay actividad — 50%+
Pharmaceuticals & Medical Research Small (1.7bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No hay actividad — 15–50%
Healthcare Services Small (1.6bn) -1–5 -$1M–$10M -0–15% 0–15%
FR Clariane SE (CLARI)
Healthcare Services Small (1.6bn) 1–5 $10M–$100M 0–15% 15–50%
Healthcare Services Small (1.6bn) 0 No hay actividad — 50%+
Pharmaceuticals & Medical Research Small (1.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No hay actividad — 0–15%
Healthcare Services Small (1.6bn) 0 No hay actividad — 0–15%
Healthcare Services Small (1.6bn) 0 No hay actividad — 0–15%
Healthcare Services Small (1.6bn) 0 No hay actividad — 50%+
Pharmaceuticals & Medical Research Small (1.6bn) 0 No hay actividad — 0–15%
US Innoviva Inc (INVA)
Pharmaceuticals & Medical Research Small (1.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No hay actividad — 0–15%
Healthcare Services Small (1.6bn) 0 No hay actividad — 15–50%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No hay actividad — 0–15%
Healthcare Services Small (1.6bn) 0 No hay actividad — 50%+
Pharmaceuticals & Medical Research Small (1.6bn) 0 No hay actividad — 0–15%
Healthcare Services Small (1.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 1–5 $100K–$1M 0–15% 50%+
Pharmaceuticals & Medical Research Small (1.6bn) 0 No hay actividad — 0–15%
Healthcare Services Small (1.6bn) 0 No hay actividad — 0–15%
Healthcare Services Small (1.5bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Small (1.5bn) 6–10 $100K–$1M 0–15% 0–15%
Healthcare Services Small (1.5bn) 0 No hay actividad — 0–15%